NCT01669772 - Study on the Effects of DA-9701 on Gastrointestinal Motility on Healthy Adult Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

December 31, 2013

Conditions

Healthy Volunteers

Interventions

DRUG

DA-9701 and placebo

Prescribe 30mg of DA-9701(motilitone) t.i.d for 1 week and then crossover to placebo.

DRUG

Placebo and DA-9701

Administer placebo 1 tablet t.i.d for 1 week. After 1 week of washout, crossover to 30mg of DA-9701 t.i.d. for 1 week.

Trial Locations (1)

Seoul St Mary's hospital, Seoul